secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cytosorbents Corp (CTSO)
CIK:        0001175151
Form:       8-K
Filed at:   2024-06-10T23:59:59+00:00
Accession:  0001104659-24-070039
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

CytoSorbents shareholders elect directors, approve executive compensation and plan amendment at annual meeting
--------------------------------------------------------------------------------

- All five director nominees (Phillip Chan, Michael Bator, Edward Jones, Alan Sobel, Jiny Kim) elected with majority of votes cast.
- Advisory vote on named executive officer compensation passed (24.3M for, 4.7M against, 0.3M abstain).
- Plan Amendment to 2014 Long-term Incentive Plan approved (20.0M for, 9.0M against, 0.2M abstain).
- Ratification of WithumSmith+Brown as independent auditor for FY2024 approved (37.5M for, 1.4M against).
- Approximately 40.0M shares voted out of 54.3M outstanding, constituting a quorum.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175151/000110465924070039/0001104659-24-070039-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175151/000110465924070039/tm2416630d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-070039

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer